This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 21 and 39
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to determine the performance of a genetic assay, GemART, in cumulus cells predictive of embryo viability, and pregnancy success in women undergoing in vitro fertilization (IVF). Performance is defined as success rate per embryo transferred, as measured by the implantation rate of embryos transferred.

Provided treatments

  • Other: Morphology
  • Other: GemART assay

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01732900. The sponsor of the trial is Gema Diagnostics and it is looking for 133 volunteers for the current phase.
Official trial title:
The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.